)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Esperion Therapeutics
Esperion Therapeutics (ESPR) investor relations material
Esperion Therapeutics has been acquired
Esperion Therapeutics EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary8 Jul, 2026
Opening remarks and agenda
Chairperson called the meeting to order at 8:00 A.M. and outlined the rules of conduct and agenda.
Notice of the meeting and proxy statement were distributed to stockholders of record as of May 28, 2026.
Quorum was confirmed, with a majority of voting power present virtually or by proxy.
Specific resolutions to be voted on
Approval of the Agreement and Plan of Merger with Essence Parent and Essence MergerCo, making the company a wholly owned subsidiary.
Advisory vote on compensation for named executive officers in connection with the merger.
Approval to adjourn the meeting if additional proxy solicitation was needed.
Overview of voting outcomes
Merger Agreement Proposal was approved by a majority of outstanding shares.
Advisory Compensation Proposal was approved by a majority of outstanding shares.
Adjournment Proposal was not addressed as the merger was approved.
Final vote counts to be reported in a Form 8-K filing within four business days.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Esperion Therapeutics
- Stockholders will vote July 8, 2026, on a merger with Essence Parent Inc. after regulatory clearance.ESPR
Proxy filing - Shareholders to vote on merger with $3.16 cash per share plus CVR; Board recommends approval.ESPRProxy filing
- Shareholders to vote on a merger with $3.16/share cash and CVR; board recommends approval.ESPRProxy filing
- All proposals passed, with no shareholder questions and strong support for board recommendations.ESPRAGM 2026
- Corstasis acquisition and sustained growth drive expansion in heart failure and global markets.ESPRThe Citizens Life Sciences Conference 2026
- Q2 revenue up 186% YoY, liquidity strengthened, and expanded labels fuel future growth.ESPRQ2 2024
- Next-gen ACLY inhibitor targets PSC with strong preclinical data and phase I trials planned for 2026.ESPRStatus Update
- Adjusted revenue up 63% year-over-year; U.S. net product revenue rose 41%; net loss $40.5M.ESPRQ1 2025
- Revenue up 186% in FY24; global expansion and pipeline drive 2025 growth targets.ESPRQ4 2024
Esperion Therapeutics
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Esperion Therapeutics, Inc. is a pharmaceutical company focused on the research, development, and commercialization of therapies to treat cardiovascular and metabolic diseases. The company specializes in developing oral, non-statin medications aimed at lowering cholesterol levels and addressing other factors contributing to cardiovascular risk. The company is headquartered in Ann Arbor, Michigan, and its shares are listed on the NASDAQ.